Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis
Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE) caused by uncontrolled activation of the complement system. Mesenchymal stem cells (MSCs) exhibit clinical efficacy for severe LN in our previous studies, but the underlying mechanisms of MSCs regulati...
Main Authors: | Haijun Ma, Chang Liu, Bingyu Shi, Zhuoya Zhang, Ruihai Feng, Minghao Guo, Liwei Lu, Songtao Shi, Xiang Gao, Wanjun Chen, Lingyun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418301993 |
Similar Items
-
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
by: Wenchao Li, et al.
Published: (2021-02-01) -
Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells
by: Bingyu Shi, et al.
Published: (2018-11-01) -
Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL- Mice
by: Zhuoya Zhang, et al.
Published: (2017-06-01) -
Allogenic Mesenchymal Stem Cell Transplantation Ameliorates Nephritis in Lupus Mice via Inhibition of B-Cell Activation
by: Xiaolei Ma, et al.
Published: (2013-12-01) -
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
by: Nicholas L. Li, et al.
Published: (2021-02-01)